ASAIO Journal最新文献_第10页

Adsorption Mass Transfer Zone of Vancomycin in Cartridges With Styrene-Divinylbenzene Sorbent. 苯乙烯-二乙烯基苯吸附剂滤芯中万古霉素的吸附传质区。

IF 3.1 3区医学

ASAIO Journal Pub Date : 2024-08-01 Epub Date: 2024-02-12 DOI: 10.1097/MAT.0000000000002166

Thiago Reis, Claudio Ronco, Gonzalo Ramírez-Guerrero, Matteo Marcello, Massimo de Cal, Francisco A R Neves, Anna Lorenzin

{"title":"Adsorption Mass Transfer Zone of Vancomycin in Cartridges With Styrene-Divinylbenzene Sorbent.","authors":"Thiago Reis, Claudio Ronco, Gonzalo Ramírez-Guerrero, Matteo Marcello, Massimo de Cal, Francisco A R Neves, Anna Lorenzin","doi":"10.1097/MAT.0000000000002166","DOIUrl":"10.1097/MAT.0000000000002166","url":null,"abstract":"Cartridges for hemoadsorption containing styrene-divinylbenzene sorbent are used for multiple conditions, such as intoxication. The mass transfer zone comprises the extension along the longitudinal span of the cartridge where adsorption occurs. The aim of this experiment is to evaluate the mass transfer zone for vancomycin in the HA380 cartridge. The experiment was carried out twice. A saline solution with vancomycin passed through a HA380-modified cartridge at 100 ml/min in a single-pass fashion. The cartridge had four openings along its longitudinal dimension, at 3, 6, 9, and 12 cm. In both experiments, the collection of aliquots occurred at minute 4, in the four openings and pre- and post-cartridge, and an additional sample from the effluent bag at the end of each experiment. In the second experiment, an additional sampling of the same six sites occurred at minute 14. The sigmoidal shape of the curve for the mass transfer zone of vancomycin was similar to the theoretical one. In experiment one, at minute 4, vancomycin clearance was 98.75 ml/min. In experiment two, vancomycin clearance at minutes 4 and 14 was 93.76 and 93.20 ml/min, respectively. This implies an adequate and optimal design of the HA380 cartridge.","PeriodicalId":8844,"journal":{"name":"ASAIO Journal","volume":" ","pages":"714-718"},"PeriodicalIF":3.1,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11280445/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139721465","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Venoarterial Extracorporeal Membrane Oxygenation Implementation in Septic Shock Rat Model. 在脓毒性休克大鼠模型中实施静脉体外膜氧合技术

IF 3.1 3区医学

ASAIO Journal Pub Date : 2024-08-01 Epub Date: 2024-02-29 DOI: 10.1097/MAT.0000000000002168

Tianlong Wang, Mingru Zhang, Wenhao Dong, Jing Wang, Han Zhang, Yuefu Wang, Bingyang Ji

{"title":"Venoarterial Extracorporeal Membrane Oxygenation Implementation in Septic Shock Rat Model.","authors":"Tianlong Wang, Mingru Zhang, Wenhao Dong, Jing Wang, Han Zhang, Yuefu Wang, Bingyang Ji","doi":"10.1097/MAT.0000000000002168","DOIUrl":"10.1097/MAT.0000000000002168","url":null,"abstract":"Septic shock, a global health concern, boasts high mortality rates. Research exploring the efficacy of venoarterial extracorporeal membrane oxygenation (VA-ECMO) in septic shock remains limited. Our study aimed to establish a rodent model employing VA-ECMO in septic shock rats, assessing the therapeutic impact of VA-ECMO on septic shock. Nineteen Sprague-Dawley rats were randomly assigned to sham, septic shock, and (septic shock + VA-ECMO; SSE) groups. Septic shock was induced by intravenous lipopolysaccharides, confirmed by a mean arterial pressure drop to 25-30% of baseline. Rats in the SSE group received 2 hours of VA-ECMO support and 60 minutes of post-weaning ventilation. Sham and septic shock groups underwent mechanical ventilation for equivalent durations. Invasive mean arterial pressure monitoring, echocardiographic examinations, and blood gas analysis revealed the efficacy of VA-ECMO in restoring circulation and ensuring adequate tissue oxygenation in septic shock rats. Post-experiment pathology exhibited the potential of VA-ECMO in mitigating major organ injury. In summary, our study successfully established a stable septic shock rat model with the implementation of VA-ECMO, offering a valuable platform to explore molecular mechanisms underlying VA-ECMO's impact on septic shock.","PeriodicalId":8844,"journal":{"name":"ASAIO Journal","volume":" ","pages":"653-660"},"PeriodicalIF":3.1,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11280450/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139989158","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Dissolved Oxygen Relevantly Contributes to Systemic Oxygenation During Venovenous Extracorporeal Membrane Oxygenation Support. 在静脉体外膜氧合支持过程中，溶解氧对全身氧合有相关贡献。

IF 3.1 3区医学

ASAIO Journal Pub Date : 2024-08-01 Epub Date: 2024-03-06 DOI: 10.1097/MAT.0000000000002171

Michael C Müller, Sarah K Wilke, Andrej Dobbermann, Sascha Kirsten, Martin Ruß, Steffen Weber-Carstens, Tobias Wollersheim

{"title":"Dissolved Oxygen Relevantly Contributes to Systemic Oxygenation During Venovenous Extracorporeal Membrane Oxygenation Support.","authors":"Michael C Müller, Sarah K Wilke, Andrej Dobbermann, Sascha Kirsten, Martin Ruß, Steffen Weber-Carstens, Tobias Wollersheim","doi":"10.1097/MAT.0000000000002171","DOIUrl":"10.1097/MAT.0000000000002171","url":null,"abstract":"When determining extracorporeal oxygen transfer (V ML O 2 ) during venovenous extracorporeal membrane oxygenation (VV ECMO) dissolved oxygen is often considered to play a subordinate role due to its poor solubility in blood plasma. This study was designed to assess the impact of dissolved oxygen on systemic oxygenation in patients with acute respiratory distress syndrome (ARDS) on VV ECMO support by differentiating between dissolved and hemoglobin-bound extracorporeal oxygen transfer. We calculated both extracorporeal oxygen transfer based on blood gas analysis using the measuring energy expenditure in extracorporeal lung support patients (MEEP) protocol and measured oxygen uptake by the native lung with indirect calorimetry. Over 20% of V ML O 2 and over 10% of overall oxygen uptake (VO 2 total ) were realized as dissolved oxygen. The transfer of dissolved oxygen mainly depended on ECMO blood flow (BF ML ). In patients with severely impaired lung function dissolved oxygen accounted for up to 28% of VO 2 total . A clinically relevant amount of oxygen is transferred as physically dissolved fraction, which therefore needs to be considered when determining membrane lung function, manage ECMO settings or guiding the weaning procedure.","PeriodicalId":8844,"journal":{"name":"ASAIO Journal","volume":" ","pages":"667-674"},"PeriodicalIF":3.1,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11280439/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140048605","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Clinical Effects of Nitric Oxide Added to the Oxygenator of Children on Extracorporeal Membrane Oxygenation: Pre-Post Cohort Study. 体外膜氧合儿童氧合器中添加一氧化氮的临床效果：前后队列研究。

IF 3.1 3区医学

ASAIO Journal Pub Date : 2024-08-01 Epub Date: 2024-02-08 DOI: 10.1097/MAT.0000000000002164

Kevin C Pan, Siva P Namachivayam, Roberto Chiletti, Derek Best, Stephen Horton, Warwick Butt

{"title":"Clinical Effects of Nitric Oxide Added to the Oxygenator of Children on Extracorporeal Membrane Oxygenation: Pre-Post Cohort Study.","authors":"Kevin C Pan, Siva P Namachivayam, Roberto Chiletti, Derek Best, Stephen Horton, Warwick Butt","doi":"10.1097/MAT.0000000000002164","DOIUrl":"10.1097/MAT.0000000000002164","url":null,"abstract":"Nitric oxide (NO) can be safely delivered through the sweep gas to the oxygenator of an extracorporeal membrane oxygenation (ECMO) circuit. It has theoretical benefits such as preventing platelet adhesion to surfaces, mitigating inflammatory response and protection against ischemia-reperfusion injury. In this uncontrolled before-after study of children on ECMO, the outcomes of those who received NO were compared with those who did not. Among 393 ECMO runs (from 337 patients), 192 of 393 (49%) received NO and 201 of 393 (51%) did not. The use of NO was associated with a 37% reduction in circuit change (adjusted risk ratio [aRR]: 0.63, 95% confidence interval [CI]: 0.42-0.93). The aRR (95% CI) for risk of neurologic injury was 0.72 (0.47-1.11). We observed potential heterogeneity of treatment effect for the risk of neurologic injury in children who had cardiac surgery: the risk with NO was lower in those who had cardiac surgery (aRR: 0.50, 95% CI: 0.26-0.96). There was no difference in survival between the study groups. In children managed with NO delivered through the ECMO circuit, we report a reduction in observed rate of circuit change and lower risk of neurologic injury in children who underwent cardiac surgery. Nitric oxide therapy on ECMO warrants prospective evaluation in children.","PeriodicalId":8844,"journal":{"name":"ASAIO Journal","volume":" ","pages":"698-703"},"PeriodicalIF":3.1,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139989157","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Percutaneous Stenting of a Stenotic Berlin Heart Outflow Cannula Graft in a 2-Year-Old Child. 狭窄的柏林心脏流出管经皮支架植入术治疗1例2岁儿童。

IF 3.1 3区医学

ASAIO Journal Pub Date : 2024-08-01 Epub Date: 2023-12-01 DOI: 10.1097/MAT.0000000000002112

Ernesto Mejia, Jason Cole, Natalie Soszyn, Scott Auerbach, Gareth J Morgan

引用次数: 0

Antibiotic Prophylaxis in Patients on Extracorporeal Membrane Oxygenation: A Systematic Review. 体外膜氧合患者的抗生素预防：系统回顾。

IF 3.1 3区医学

ASAIO Journal Pub Date : 2024-08-01 Epub Date: 2024-03-19 DOI: 10.1097/MAT.0000000000002192

Ranjit Sah, Sangam Shah, Prativa Subedi, Ashutosh Kashyap, Anil Kc, Deepa Wosti, Devang Sanghavi, Anirban Bhattacharyya, Pramod Guru, Sanjay Chaudhary

{"title":"Antibiotic Prophylaxis in Patients on Extracorporeal Membrane Oxygenation: A Systematic Review.","authors":"Ranjit Sah, Sangam Shah, Prativa Subedi, Ashutosh Kashyap, Anil Kc, Deepa Wosti, Devang Sanghavi, Anirban Bhattacharyya, Pramod Guru, Sanjay Chaudhary","doi":"10.1097/MAT.0000000000002192","DOIUrl":"10.1097/MAT.0000000000002192","url":null,"abstract":"Despite the frequent use of prophylactic antibiotics in hospitals for extracorporeal membrane oxygenation (ECMO) patients, the Extracorporeal Life Support Organization (ELSO) Infectious Disease Task Force does not recommend routine antibiotic prophylaxis due to a lack of compelling evidence. We assessed the effectiveness of prophylactic antibiotics in ECMO patients. We conducted a comprehensive search of multiple databases from their inception up to September 6, 2023, on various databases using keywords like \"antibiotics,\" \"prophylaxis,\" \"extracorporeal membrane oxygenation,\" and \"ECMO.\" Newcastle-Ottawa Scale (NOS) was used to assess the quality of the included research. We collected data using Microsoft Excel version 2016, mean and standard deviations were calculated for continuous data, while frequencies and percentages were calculated for binomial data. A total of three studies was included in the review with a total of 8,954 participants, of which 4,483 (50.06%) received antibiotic prophylaxis, and 1,131 (25.22%) were female. The administration of antibiotics prophylactically was associated with reduction in rate of mortality, the risk of infections, and complications like acute kidney injury and diarrhea. Although there have been some benefits on antibiotic prophylaxis, prospective research, and possibly the creation of tailored, ECMO-specific bundles will be needed to identify efficient ways to prevent ECMO infection.","PeriodicalId":8844,"journal":{"name":"ASAIO Journal","volume":" ","pages":"e103-e107"},"PeriodicalIF":3.1,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140179342","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Prehabilitation Maximizing Functional Mobility in Patients With Cardiogenic Shock Supported on Axillary Impella. 通过康复训练最大限度地提高腋下冲击泵支持的心源性休克患者的功能活动能力。

IF 3.1 3区医学

ASAIO Journal Pub Date : 2024-08-01 Epub Date: 2024-03-14 DOI: 10.1097/MAT.0000000000002170

Anju Bhardwaj, Ismael A Salas de Armas, Amanda Bergeron, R Michelle Sauer, Christa Gilley, Kathryn Reeves, Maria Patarroyo-Aponte, Mehmet H Akay, Manish Patel, Sachin Kumar, Jayeshkumar Patel, Juan Marcano, Sriram Nathan, Igor D Gregoric, Biswajit Kar

{"title":"Prehabilitation Maximizing Functional Mobility in Patients With Cardiogenic Shock Supported on Axillary Impella.","authors":"Anju Bhardwaj, Ismael A Salas de Armas, Amanda Bergeron, R Michelle Sauer, Christa Gilley, Kathryn Reeves, Maria Patarroyo-Aponte, Mehmet H Akay, Manish Patel, Sachin Kumar, Jayeshkumar Patel, Juan Marcano, Sriram Nathan, Igor D Gregoric, Biswajit Kar","doi":"10.1097/MAT.0000000000002170","DOIUrl":"10.1097/MAT.0000000000002170","url":null,"abstract":"Physical therapy (PT) benefits for critically ill patients are well recognized; however, little data exist on PT in patients receiving temporary mechanical circulatory support. In this single-center retrospective study (February 2017-January 2022), we analyzed 37 patients who received an axillary Impella device (Abiomed, Danvers, MA) and PT to \"prehabilitate\" them before durable left ventricular assist device (dLVAD) implantation. The Activity Measure for Post-Acute Care (AM-PAC) Basic Mobility tool assessed the functional status at different points during admission. Immediately after Impella placement, the median AM-PAC score was 12.7 (interquartile range [IQR], 9-15), and the scores continued to significantly increase to 18.4 (IQR, 16-23) before dLVAD and up to 20.7 (IQR, 19-24) at discharge, indicating improved independence. No PT-related complications were reported. Thus, we hypothesize that critically ill patients initially deemed equivocal candidates may safely participate in PT while maximizing functional activities before dLVAD placement.","PeriodicalId":8844,"journal":{"name":"ASAIO Journal","volume":" ","pages":"661-666"},"PeriodicalIF":3.1,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140130655","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Meet the Authors. 与作者见面

IF 3.1 3区医学

ASAIO Journal Pub Date : 2024-08-01 Epub Date: 2024-07-26 DOI: 10.1097/01.mat.0001027860.54259.c8

引用次数: 0

Development and First Clinical Use of an Extracorporeal Artificial Multiorgan System in Acute-on-Chronic Liver Failure Patients. 体外人工多器官系统在急性慢性肝衰竭患者中的开发和首次临床应用。

IF 3.1 3区医学

ASAIO Journal Pub Date : 2024-08-01 Epub Date: 2024-02-28 DOI: 10.1097/MAT.0000000000002174

Suhail Ahmad, Alexander Novokhodko, Iris W Liou, Nancy Colobong Smith, Robert L Carithers, Jorge Reyes, Ramasamy Bakthavatsalam, Carl Martin, Renuka Bhattacharya, Nanye Du, Shaohang Hao, Dayong Gao

{"title":"Development and First Clinical Use of an Extracorporeal Artificial Multiorgan System in Acute-on-Chronic Liver Failure Patients.","authors":"Suhail Ahmad, Alexander Novokhodko, Iris W Liou, Nancy Colobong Smith, Robert L Carithers, Jorge Reyes, Ramasamy Bakthavatsalam, Carl Martin, Renuka Bhattacharya, Nanye Du, Shaohang Hao, Dayong Gao","doi":"10.1097/MAT.0000000000002174","DOIUrl":"10.1097/MAT.0000000000002174","url":null,"abstract":"Multiple organ failure (MOF) is a common and deadly condition. Patients with liver cirrhosis with acute-on-chronic liver failure (AOCLF) are particularly susceptible. Excess fluid accumulation in tissues makes routine hemodialysis generally ineffective because of cardiovascular instability. Patients with three or more organ failures face a mortality rate of more than 90%. Many cannot survive liver transplantation. Extracorporeal support systems like MARS (Baxter, Deerfield, IL) and Prometheus (Bad Homburg, Germany) have shown promise but fall short in bridging patients to transplantation. A novel Artificial Multi-organ Replacement System (AMOR) was developed at the University of Washington Medical Center. AMOR removes protein-bound toxins through a combination of albumin dialysis, a charcoal sorbent column, and a novel rinsing method to prevent sorbent column saturation. It removes excess fluid through hemodialysis. Ten AOCLF patients with over three organ failures were treated by the AMOR system. All patients showed significant clinical improvement. Fifty percent of the cohort received liver transplants or recovered liver function. AMOR was successful in removing large amounts of excess body fluid, which regular hemodialysis could not. AMOR is cost-effective and user-friendly. It removes excess fluid, supporting the other vital organs such as liver, kidneys, lungs, and heart. This pilot study's results encourage further exploration of AMOR for treating MOF patients.","PeriodicalId":8844,"journal":{"name":"ASAIO Journal","volume":"70 8","pages":"690-697"},"PeriodicalIF":3.1,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141854623","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Hemodynamic Optimization by Invasive Ramp Test in Patients Supported With HeartMate 3 Left Ventricular Assist Device. 使用 HeartMate 3 左心室辅助装置的患者通过侵入性斜坡测试优化血液动力学。

IF 3.1 3区医学

ASAIO Journal Pub Date : 2024-08-01 Epub Date: 2024-02-19 DOI: 10.1097/MAT.0000000000002167

Gal Rubinstein, Cathrine M Moeller, Dor Lotan, Sharon Slomovich, Andrea Fernandez-Valledor, Daniel Oren, Kyung T Oh, Justin A Fried, Kevin J Clerkin, Jayant K Raikhelkar, Veli K Topkara, Yuji Kaku, Koji Takeda, Yoshifumi Naka, Daniel Burkhoff, Farhana Latif, David Majure, Paolo C Colombo, Melana Yuzefpolskaya, Gabriel T Sayer, Nir Uriel

{"title":"Hemodynamic Optimization by Invasive Ramp Test in Patients Supported With HeartMate 3 Left Ventricular Assist Device.","authors":"Gal Rubinstein, Cathrine M Moeller, Dor Lotan, Sharon Slomovich, Andrea Fernandez-Valledor, Daniel Oren, Kyung T Oh, Justin A Fried, Kevin J Clerkin, Jayant K Raikhelkar, Veli K Topkara, Yuji Kaku, Koji Takeda, Yoshifumi Naka, Daniel Burkhoff, Farhana Latif, David Majure, Paolo C Colombo, Melana Yuzefpolskaya, Gabriel T Sayer, Nir Uriel","doi":"10.1097/MAT.0000000000002167","DOIUrl":"10.1097/MAT.0000000000002167","url":null,"abstract":"In patients supported by the HeartMate 3 left ventricular assist device (HM3 LVAD), pump speed adjustments may improve hemodynamics. We investigated the hemodynamic implications of speed adjustments in HM3 recipients undergoing hemodynamic ramp tests. Clinically stable HM3 recipients who underwent routine invasive hemodynamic ramp tests between 2015 and 2022 at our center were included. Filling pressure optimization, defined as central venous pressure (CVP) <12 mm Hg and pulmonary capillary wedge pressure (PCWP) <18 mm Hg, was assessed at baseline and final pump speeds. Patients with optimized pressures were compared to nonoptimized patients. Overall 60 HM3 recipients with a median age of 62 years (56, 71) and time from LVAD implantation of 187 days (124, 476) were included. Optimized filling pressures were found in 35 patients (58%) at baseline speed. Speed was adjusted in 84% of the nonoptimized patients. Consequently, 39 patients (65%) had optimized pressures at final speed. There were no significant differences in hemodynamic findings between baseline and final speeds ( p > 0.05 for all). Six and 12 month readmission-free rates were higher in optimized compared with nonoptimized patients ( p = 0.03 for both), predominantly due to lower cardiac readmission-free rates ( p = 0.052). In stable outpatients supported with HM3 who underwent routine ramp tests, optimized hemodynamics were achieved in only 2 of 3 of the patients. Patients with optimized pressures had lower all-cause readmission rates, primarily driven by fewer cardiac-related hospitalizations.","PeriodicalId":8844,"journal":{"name":"ASAIO Journal","volume":" ","pages":"641-650"},"PeriodicalIF":3.1,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139904948","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0